2020
March 2020
- The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation.
Chatonnet F, Pignarre A, Sérandour AA, Caron G, Avner S, Robert N, Kassambara A, Laurent A, Bizot M, Agirre X, Prosper F, Martin-Subero JI, Moreaux J, Fest T, Salbert G. Haematologica. 2020 Mar;105(3):774-783. - Radiotherapy-induced overexpression of exosomal miRNA-378a-3p in cancer cells limits natural killer cells cytotoxicity.
Briand J, Garnier D, Nadaradjane A, Clément-Colmou K, Potiron V, Supiot S, Bougras-Cartron G, Frenel JS, Heymann D, Vallette FM, Cartron PF. Epigenomics. 2020 Mar;12(5):397-408. - microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation.
Labbé M, Hoey C, Ray J, Potiron V, Supiot S, Liu SK, Fradin D. Mol Cancer. 2020 Mar 23;19(1):63.
February 2020
- Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme.
Cheray M, Etcheverry A, Jacques C, Pacaud R, Bougras-Cartron G, Aubry M, Denoual F, Peterlongo P, Nadaradjane A, Briand J, Akcha F, Heymann D, Vallette FM, Mosser J, Ory B, Cartron PF. Mol Cancer. 2020 Feb 25;19(1):36. - MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma.
Vignard V, Labbé M, Marec N, André-Grégoire G, Jouand N, Fonteneau JF, Labarrière N, Fradin D. Cancer Immunol Res. 2020 Feb;8(2):255-267.
January 2020
- Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells.
Ménard C, Dulong J, Roulois D, Hébraud B, Verdière L, Pangault C, Sibut V, Bezier I, Bescher N, Monvoisin C, Gadelorge M, Bertheuil N, Flécher E, Casteilla L, Collas P, Sensebé L, Bourin P, Espagnolle N, Tarte K. Stem Cells. 2020 Jan;38(1):146-159. - Epigenetic protein complexes: the adequate candidates for the use of a new generation of epidrugs in personalized and precision medicine in cancer.
Cartron PF, Cheray M, Bretaudeau L. Epigenomics. 2020 Jan;12(2):171-177. - Cell-free circulating epimarks in cancer monitoring. Duforestel M, Briand J, Bougras-Cartron G, Heymann D, Frenel JS, Vallette FM, Cartron PF. Epigenomics. 2020 Jan;12(2):145-155.
- Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: a role in cancer therapy? Sylvestre M, Tarte K, Roulois D. Epigenomics. 2020 Jan;12(2):157-169.
- BET bromodomains' functions in bone-related pathologies. Jacques C, Lavaud M, Georges S, Tesfaye R, Baud'huin M, Lamoureux F, Ory B. Epigenomics. 2020 Jan;12(2):127-144.
- Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma. Rabé M, Dumont S, Álvarez-Arenas A, Janati H, Belmonte-Beitia J, Calvo GF, Thibault-Carpentier C, Séry Q, Chauvin C, Joalland N, Briand F, Blandin S, Scotet E, Pecqueur C, Clairambault J, Oliver L, Perez-Garcia V, Nadaradjane A, Cartron PF, Gratas C, Vallette FM. Cell Death Dis. 2020 Jan 6;11(1):19.